Iovance Biotherapeutics, Inc. · NASDAQ:IOVA

Puri Raj K. exercised options for 9,766 Iovance Biotherapeutics, Inc. shares (Form 4)

Traded Jun 5, 2026 · Filed Jun 9, 2026

On Jun 5, 2026, Puri Raj K. (Chief Regulatory Officer) exercised options for 9,766 Iovance Biotherapeutics, Inc. shares, leaving 248,114 shares. Filed Jun 9, 2026 (Form 4).

Options exercised
9,766 shares
Holding after
248,114 shares
Trading plan
No
Role
Chief Regulatory Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 5, 2026Common StockOption exercise9,766251,957Direct
Jun 5, 2026Common StockShares withheld for tax3,843US$4.23248,114Direct

Source

View original at SEC

Related